C34 PEG 4 Chol
Alternative Names: C34 polyethylene glycol 4 cholesterol; HIVP 3; Peptivir-HLatest Information Update: 28 Jul 2018
At a glance
- Originator PeptiPharma
- Developer Imperial College of Science, Technology and Medicine
- Class Antivirals; Lipids; Polyethylene glycols
- Mechanism of Action HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in HIV-infections in United Kingdom (SC, Injection)
- 15 Feb 2015 Phase-I clinical trials in HIV infections in United Kingdom (SC)